IP Library Granted Patent US 7,531,178
Granted Patent B2
US 7,531,178 · App. 11/009,106 · Granted May 12, 2009

Immunoadhesin comprising a glycoprotein VI domain

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,531,178
App. No.
11/009,106
Granted
May 12, 2009
Kind
B2
Abstract

The present invention provides a fusion protein comprising (1) the extracellular domain of glycoprotein VI or a variant thereof that is functional for binding to collagen and (b) the Fc domain of the immunoglobulin or a function-conservative part thereof, characterized by a polypeptide chain having an amino acid sequence as shown in FIG. 7 and whereby the fusion protein is obtainable by a process which provides the fusion protein in the form of a specific dimer.

Claims (12)

1. A protein obtained by expressing a DNA sequence in a mammalian cell wherein the DNA sequence comprises, in a 5′ to 3′ direction:

(i) a DNA sequence comprising bases 1 to 807 of SEQ ID NO: 2 having collagen binding activity;

(ii) a DNA sequence comprising bases 808 to 816 of SEQ ID NO: 2; and

(iii) a DNA sequence comprising bases 817 to 1515 of SEQ ID NO: 2,

wherein said DNA sequence encodes an amino acid sequence which comprises a hinge region of an immunoglobulin, the hinge region containing at least two cysteines, and is functional to prolong plasma half life of the protein beyond that of a protein whose amino acid sequence consists of an amino acid sequence encoded by said DNA sequences (i) and (ii);

wherein said protein binds collagen.

2. A dimeric protein of two polypeptide monomers, wherein the amino acid sequence of each polypeptide monomer is the sequence of SEQ ID NO: 1.

3. The dimeric protein of claim 2 , wherein said protein is glycosylated.

4. A fusion protein whose amino acid sequence comprises the sequence of SEQ ID NO: 1.

5. A fusion protein whose amino acid sequence consists of the sequence of SEQ ID NO: 1.

6. A composition comprising the dimeric protein of claim 2 and a pharmaceutically acceptable carrier.

7. A protein obtained by expressing a DNA sequence consisting of the sequence of SEQ ID NO: 2 in a CHO cell.

Assignments (5)
CHANGE OF NAME Recorded Feb 16, 2017
From: AVA VIER VERMÖGENSVERWALTUNG GMBH
To: ADVANCECOR GMBH
Reel/Frame 041280/0422 →
ASSET SALE DOCUMENTATION Recorded Feb 16, 2017
From: CORIMMUN GMBH
To: AVA VIER VERMÖGENSVERWALTUNG GMBH
Reel/Frame 041739/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2010
From: TRIGEN GMBH
To: CORIMMUN GMBH
Reel/Frame 025313/0133 →
CHANGE OF NAME Recorded Jul 24, 2007
From: PROCORDE GMBH
To: TRIGEN GMBH
Reel/Frame 019604/0665 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2005
From: MASSBERG, STEFFEN; GAWAZ, MEINRAD; BULTMANN, ANDREAS; MUNCH, GOTZ; UNGERER, MARTIN; PELUSO, MARIO
To: PROCORDE GMBH
Reel/Frame 016661/0503 →